Bioinformatics analyses reveal that LPAR6 acts as a tumor suppressor in breast cancer and may inhibit tumor progression by facilitating the formation of RB1/E2F family complexes to induce cell cycle arrest. This evidence concerns the gene RB1 and breast carcinoma.